Table 1 Correlation between clinicopathologic characteristics and increased percent positive staining for CD10.
From: Differential expression of CD10 in prostate cancer and its clinical implication
n | Spearman Coefficient | P value | |
|---|---|---|---|
Increasing Pre-treatment PSA | 81 | 0.3 | 0.006 |
Stage ≥ pT3 | 38 | 0.234 | 0.03 |
Gleason ≥ 7 | 69 | 0.336 | 0.001 |